Latest California Healthline Stories
Tres cosas sobre el debate del aborto que se entienden mal
Uno de los mitos: que la decisión de la Corte Suprema afecta solo a las mujeres que quieren realizarse el procedimiento, cuando en realidad afecta a toda la salud reproductiva.
KHN’s ‘What the Health?’: Drug Price Bill Is a Go in the Senate
Two things happened in Washington this week that were inevitable: President Joe Biden tested positive for covid-19, and the Senate agreed to move forward on a budget bill that includes only a sliver of what Biden hoped it would. Still, the bill to allow Medicare to negotiate some drug prices, cap out-of-pocket drug costs for seniors, and extend temporary subsidies for Affordable Care Act insurance premiums would represent a major step if Democrats can get it across the finish line. Meanwhile, abortion battles continue to escalate around the country, with Texas leading the way in restrictions. Shefali Luthra of The 19th, Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Dr. Jack Resneck Jr., the new president of the American Medical Association.
Parents Become Drug Developers to Save Their Children’s Lives
Families affected by ultra-rare diseases are starting their own companies to speed the development of treatments for their kids, venturing into territory that traditional drugmakers deem too risky.
‘So Rudderless’: A Couple’s Quest for Autism Treatment for Their Son Hits Repeated Obstacles
Amparo and Victor Rios began searching for answers about their son’s development when he didn’t hit some milestones after turning 2. Three years later, they are still trying to get their insurance to pay for expensive therapy to help him.
Watch: Why the Public Health System Is Having Trouble Containing Monkeypox
KHN Midwest correspondent Lauren Weber appeared on CBS News’ streaming network to discuss “Fighting Monkeypox, Sexual Health Clinics Are Underfunded and Ill-Equipped,” an article she wrote with KHN senior correspondent Liz Szabo. It details how ill-equipped the nation’s sexual health clinics and public health system are to tackle monkeypox after decades of underfunding. Weber described […]
Critics Worry Government Surveillance of HIV May Hurt More Than It Helps
Some people living with HIV and some state health officials are raising concerns about part of the federal effort to end the HIV epidemic: a new technology that analyzes blood samples to find emerging outbreaks. The critics say it’s too invasive and stigmatizing and might not be more effective than older public health approaches.
In Some States, Voters Will Get to Decide the Future of Abortion Rights
Measures to enshrine the right to abortion in the state constitution will be on the ballot in California and Vermont this fall. Abortion-rights advocates in Michigan are hoping their state will follow suit.
Fighting Monkeypox, Sexual Health Clinics Are Underfunded and Ill-Equipped
Sexual health clinics are scrambling to properly track, test, and treat hundreds of monkeypox patients. So far, it isn’t going well.
Las clínicas de salud sexual luchan sin medios contra la viruela del simio
Las clínicas que tratan las enfermedades de transmisión sexual —que ya se enfrentaban a un aumento explosivo de enfermedades como la sífilis y la gonorrea— se encuentran ahora en la primera línea de la lucha para controlar el brote de viruela del simio, que crece rápidamente.
Boost Now or Wait? Many Wonder How Best to Ride Out Covid’s Next Wave
As the country faces a rise in new infections driven by the omicron BA.5 subvariant of the coronavirus, about 70% of people 50 and older who got a first covid-19 booster shot haven’t received the recommended second one, according to the Centers for Disease Control and Prevention. Many undervaccinated Americans have lost interest, and others aren’t sure whether to get boosted again now or wait for vaccines reformulated to target newer strains of the virus.